Seres Therapeutics, Inc. financial data

Symbol
MCRB on Nasdaq
Location
200 Sidney Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Seres Health, Inc. (to 5/14/2015)
Latest financial report
8-K - Q4 2023 - Aug 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 183 % -30.1%
Quick Ratio 37.2 %
Debt-to-equity -772 % -132%
Return On Equity 314 %
Return On Assets -46.7 % -1.7%
Operating Margin -42.2K % -36968%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 152M shares +18.4%
Common Stock, Shares, Outstanding 152M shares +18.4%
Entity Public Float 463M USD +93%
Common Stock, Value, Issued 152K USD +18.8%
Weighted Average Number of Shares Outstanding, Basic 152M shares +18.6%
Weighted Average Number of Shares Outstanding, Diluted 152M shares +16.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 374K USD -99.7%
Revenue from Contract with Customer, Excluding Assessed Tax 7.13M USD -95%
Research and Development Expense 94.7M USD -47.4%
General and Administrative Expense 68.7M USD -24.7%
Operating Income (Loss) -158M USD -6.34%
Nonoperating Income (Expense) -4.24M USD +14.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -162M USD -5.66%
Earnings Per Share, Basic -1.17 USD/shares +3.31%
Earnings Per Share, Diluted -1.17 USD/shares +3.31%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 71.2M USD -69%
Inventory, Net 53M USD +892%
Assets, Current 149M USD -40.6%
Property, Plant and Equipment, Net 17.8M USD -25.9%
Operating Lease, Right-of-Use Asset 103M USD -6.35%
Other Assets, Noncurrent 41.5M USD +269%
Assets 322M USD -20.8%
Accounts Payable, Current 4.81M USD -62.8%
Employee-related Liabilities, Current 7.44M USD -36.4%
Liabilities, Current 108M USD +39%
Operating Lease, Liability, Noncurrent 101M USD -5.41%
Other Liabilities, Noncurrent 1.73M USD +12.9%
Liabilities 409M USD +6.52%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.05B USD -18.2%
Stockholders' Equity Attributable to Parent -87.1M USD -485%
Liabilities and Equity 322M USD -20.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.2M USD +54%
Net Cash Provided by (Used in) Financing Activities 18.8M USD +232%
Net Cash Provided by (Used in) Investing Activities -62K USD -102%
Common Stock, Shares Authorized 360M shares +50%
Common Stock, Shares, Issued 152M shares +18.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -68.2M USD -156%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 81.1M USD -65.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.58M USD +106%
Deferred Tax Assets, Valuation Allowance 313M USD +12.8%
Deferred Tax Assets, Gross 342M USD +11.4%
Operating Lease, Liability 110M USD -1.82%
Payments to Acquire Property, Plant, and Equipment 62K USD -98.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -162M USD -5.84%
Lessee, Operating Lease, Liability, to be Paid 168M USD -7.94%
Property, Plant and Equipment, Gross 71.6M USD -0.53%
Operating Lease, Liability, Current 9.2M USD +68.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.7M USD +5.19%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.1M USD +13.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 58.3M USD -17.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.3M USD +5.38%
Deferred Tax Assets, Operating Loss Carryforwards 143M USD +7.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 13.5M USD +7.99%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.6M USD
Operating Lease, Payments 17.3M USD +48.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.3M USD -0.1%
Share-based Payment Arrangement, Expense 25.8M USD -24.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%